Robert H Christenson Selected Research

Iothalamic Acid (Iotalamic Acid)

1/2018	Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis.
1/2018	Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis.
4/2016	Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and Dimethylarginines.
4/2014	Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert H Christenson Research Topics

Disease

51	Heart Failure 03/2022 - 10/2003
47	Myocardial Infarction 11/2022 - 02/2002
42	Acute Coronary Syndrome 06/2022 - 06/2002
20	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 11/2002
12	Chest Pain (Chest Pains) 11/2022 - 01/2001
10	Chronic Renal Insufficiency 03/2022 - 03/2008
10	Necrosis 04/2021 - 01/2001
10	Inflammation (Inflammations) 01/2021 - 05/2002
9	Coronary Artery Disease (Coronary Atherosclerosis) 11/2022 - 01/2001
8	Dyspnea (Shortness of Breath) 01/2022 - 08/2007
8	Unstable Angina 01/2021 - 12/2002
8	Fibrosis (Cirrhosis) 01/2018 - 07/2012
7	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 08/2002
7	Infarction (Infarctions) 04/2021 - 09/2003
6	Atherosclerosis 01/2019 - 05/2002
5	ST Elevation Myocardial Infarction 01/2021 - 08/2005
5	Heart Diseases (Heart Disease) 04/2017 - 01/2001
5	Ischemia 03/2017 - 05/2005
4	Stroke (Strokes) 10/2020 - 12/2009
4	Wounds and Injuries (Trauma) 01/2020 - 01/2008
3	Hemolysis 01/2022 - 10/2003
3	Neoplasms (Cancer) 01/2022 - 05/2010
3	Cardiomyopathies (Cardiomyopathy) 01/2020 - 12/2006
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2019 - 05/2003
3	Kidney Diseases (Kidney Disease) 01/2018 - 12/2012
3	Coronary Disease (Coronary Heart Disease) 07/2015 - 09/2012
3	Chronic Kidney Failure (Chronic Renal Failure) 09/2014 - 05/2002
3	Left Ventricular Dysfunction 01/2009 - 12/2003
2	Death (Near-Death Experience) 01/2022 - 01/2021
2	COVID-19 01/2021 - 01/2021
2	Non-ST Elevated Myocardial Infarction 01/2021 - 03/2015
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 01/2020
2	Ascites 04/2016 - 01/2014
2	Overweight 01/2016 - 04/2010
2	Hypertension (High Blood Pressure) 05/2015 - 09/2014
2	Sepsis (Septicemia) 04/2014 - 12/2007
2	Renal Insufficiency (Renal Failure) 01/2014 - 04/2011
2	Atrial Fibrillation 03/2013 - 11/2009
2	Hyperlipidemias (Hyperlipidemia) 05/2010 - 10/2003
2	Jaundice (Icterus) 05/2010 - 10/2003
2	Diabetes Mellitus 11/2009 - 09/2007
2	Critical Illness (Critically Ill) 01/2008 - 12/2007
1	Fever (Fevers) 01/2022
1	Pathologic Constriction (Stenosis) 01/2021
1	Brain Concussion (Cerebral Concussion) 01/2020
1	Carcinogenesis 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 10/2019

Drug/Important Bio-Agent (IBA)

63	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2001
34	TroponinIBA 11/2022 - 01/2001
27	Troponin T (Troponin T1)IBA 05/2022 - 02/2003
27	Brain Natriuretic Peptide (Natrecor)FDA Link 03/2022 - 12/2006
27	pro-brain natriuretic peptide (1-76)IBA 03/2022 - 12/2006
18	Troponin IIBA 01/2021 - 04/2003
12	trans-crotonin (CTN)IBA 01/2022 - 03/2008
11	Natriuretic PeptidesIBA 03/2017 - 12/2003
10	MB Form Creatine KinaseIBA 09/2017 - 04/2003
6	CreatinineIBA 04/2016 - 03/2004
6	Creatine Kinase (Creatine Phosphokinase)IBA 10/2014 - 01/2001
5	C-Reactive ProteinIBA 01/2021 - 05/2002
5	Galectin 3 (LGALS3)IBA 01/2020 - 05/2010
4	Iothalamic Acid (Iotalamic Acid)FDA Link 01/2018 - 04/2014
4	Cystatin CIBA 01/2018 - 12/2012
4	MyoglobinIBA 09/2017 - 04/2003
3	omega-Chloroacetophenone (Mace)IBA 11/2022 - 05/2015
3	insulin-like growth factor binding protein-related protein 1IBA 01/2022 - 01/2020
3	AntibodiesIBA 01/2022 - 05/2010
3	Growth Differentiation Factor 15IBA 07/2020 - 03/2017
2	Dobutamine FDA LinkGeneric 04/2021 - 11/2005
2	MicroRNAs (MicroRNA)IBA 04/2021 - 01/2021
2	SodiumIBA 01/2021 - 01/2018
2	Glial Fibrillary Acidic ProteinIBA 01/2020 - 01/2018
2	CytokinesIBA 02/2017 - 05/2005
2	CholesterolIBA 09/2016 - 12/2006
2	DiureticsIBA 04/2016 - 01/2014
2	proadrenomedullinIBA 05/2015 - 04/2014
2	MineralsIBA 04/2015 - 05/2010
2	Biological ProductsIBA 04/2014 - 02/2008
2	ProcalcitoninIBA 04/2014 - 03/2012
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2013 - 06/2002
2	antigen CYFRA21.1IBA 04/2012 - 05/2003
2	Indicators and Reagents (Reagents)IBA 06/2011 - 03/2004
2	EnzymesIBA 08/2005 - 09/2003
2	Eptifibatide (Integrilin)FDA Link 12/2003 - 12/2002
2	paragonIBA 04/2003 - 02/2003
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	AlbuminsIBA 01/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021
1	N 30IBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2020
1	EsterasesIBA 01/2020
1	UbiquitinIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 08/2019
1	ErbB Receptors (EGF Receptor)IBA 08/2019

Therapy/Procedure

13	Therapeutics 01/2022 - 11/2002
3	Percutaneous Coronary Intervention 01/2022 - 03/2004
3	Renal Dialysis (Hemodialysis) 01/2019 - 09/2007
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2022 - 01/2022
2	Critical Care (Surgical Intensive Care) 04/2014 - 01/2008
1	Dietary Approaches To Stop Hypertension 01/2021